Format

Send to

Choose Destination
Curr Treat Options Neurol. 2010 Jan;12(1):16-28. doi: 10.1007/s11940-009-0055-z.

Myotonia congenita and myotonic dystrophy: surveillance and management.

Author information

1
Department of Pediatrics, Tulane University, 1430 Tulane Avenue, SL-37, New Orleans, LA, 70112, USA, aconrave@tulane.edu.

Abstract

Myotonia can be treated both pharmacologically and by lifestyle modifications. Cell membrane stabilizers are the medications most commonly used for symptomatic treatment of myotonia. Most patients do not require treatment for the myotonia itself, unless it is severe, but physicians must be aware of anesthesia risks in both myotonia congenita and myotonic dystrophy. A mainstay of management of myotonic dystrophy is the surveillance and treatment of its various systemic complications.

PMID:
20842486
DOI:
10.1007/s11940-009-0055-z

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center